Science & Technology
Bispecific upstages Keytruda
Immunotherapy has revolutionized cancer treatment, with checkpoint inhibitors like Keytruda (pembrolizum...
News and insights
Bispecific Antibody
Science & Technology
First-in-class T cell engager approved for lung cancer
Small cell lung cancer (SCLC) remains one of the most aggressive and challenging cancers to treat, with ...